(1) Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA; (2) Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA

(1) Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; (2) Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang-Ming University, Taipei, Taiwan; (3) Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; (4) Division of Hematology/Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; (5) Division of Cardiology, National Yang Ming University Hospital, I-Lan, Taiwan

(1) Rheumatology Clinical Immunology, University Medical Center, Utrecht, The Netherlands; (2) Haematology Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands; (3) Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

(1) Medical University of Vienna, Austria; (2) University Paris Sud (Paris XI), INSERM U 999, Hôpital Bicêtre, Le Kremlin Bicêtre, France; (3) Papworth Hospital, Cambridge, UK; (4) Kerckhoff Clinic Heart and Lung Centre, Bad Nauheim, Germany; (5) Clinical Department of Cardiology and Angiology of the First Faculty of Medicine and General Teaching Hospital, Prague; (6) Hospital Clínic–Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CIBER Enfermedades Respiratorias, Universtiy of Barcelona, Spain; (7) Medical Centre of Postgraduate Education, ECZ, Otwock, Poland; (8) Aarhus University Hospital, Skejby, Aarhus, Denmark; (9) University Hospital Gasthuisberg, Leuven, Belgium

(1) Hematology Service, University Clinic of Navarra, Pamplona, Spain; (2) Documentation Service, University Clinic of Navarra, Pamplona, Spain; (3) Informatics Service, University Clinicof Navarra, Pamplona, Spain; (4) Oncology Department, University Clinic of Navarra, Pamplona, Spain; (5) Division of Cardiovascular Sciences, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain; (6) Department of Medicine, McMaster University, Hamilton, Ontario, Canada

(1) Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan; (2) Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; (3) Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan; (4) Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan; (5) Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

(1) Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; (2) Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China; (3) Department of Laboratory Medicine and Pathology, Children’s Hospital, Boston, Harvard Medical School, Massachusetts, USA; (4) Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

(1) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

(1) Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA 

(1) Research Center On Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy

(1) Department of Haematology-Haemostasis, University Hospital of Tours, Tours Cedex, France; (2) UMR CNRS 7292 and François Rabelais University, Tours, France; (3) Hyphen Biomed, Neuville sur Oise, France; (4) Department of Cardiac Surgery, University Hospital of Tours, Tours Cedex, France

(1) Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Pennsylvania, USA; (2) The University of Pennsylvania, Philadelphia Perelman School of Medicine, Philadelphia, Pennsylvania, USA; (3) Blood Research Institute, Blood Center of Wisconsin, and Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

(1) Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences,University of Birmingham, Birmingham, UK

(1) Global Drug Discovery, Bayer HealthCare Pharmaceuticals AG, Wuppertal, Germany; (2) Department of Biomedical Engineering, Oregon Health and Science University, School of Medicine, Portland, Oregon, USA; (3) Bioanalytics, Bayer HealthCare Pharmaceuticals AG, Wuppertal, Germany

(1) Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan; (2) Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan; (3) Divisions of Community and Family Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan; (4) Department of Pediatrics, Nara Medical University, Nara, Japan; (5) Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan; (6) Research Division, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan

(1) Medizinische Klinik III, Klinik für Kardiologie und Kreislauferkrankungen, Eberhard Karls-Universität Tübingen, Tübingen, Germany; (2) Medizinische Klinik III, Institut für Klinische Chemie und Institut für Physiologie, Technische Universität Dresden, Dresden, Germany

(1) Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University, Aachen, Germany; (2) Institute of Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany; (3) Center for Physiology and Pharmacology, Department of Vascular Biology and Thrombosis Research, Medical University Vienna, Vienna, Austria; (4) European Vascular Center Aachen-Maastricht, Department of Vascular Surgery, RWTH Aachen University, Aachen, Germany; (5) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany; (6) Munich Heart Alliance, Munich, Germany; (7) Cardiovascular Research Institute Maastricht (CARIM), Maastricht University,The Netherlands; (8) August-Lenz-Stiftung, Institute for Cardiovascular Research, Ludwig-Maximilians-University Munich, Munich, Germany

(1) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan; (2) Department of Regulatory Medicine for Thrombosis, Nara Medical University, Kashihara, Nara, Japan; (3) Department of Anesthesiology, Nara Medical University, Kashihara, Nara, Japan

(1) Heart Diseases Institute, Bellvitge University Hospital – IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain; (2) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

(1) Department of LaboratoryMedicine, Clinical Chemistry, University of Lund, University Hospital, Malmö, Sweden; (2) Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy; (3) Inserm UMR-S 973, University Paris Diderot, Paris, France

(1) Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Cà Granda Maggiore Hospital Foundation, and University of Milan, Milan, Italy; (2) U.O.S. Dipartimentale per la Diagnosi e la Terapia delle Coagulopatie, Milan, Italy; (3) Central Laboratory of Chemical Analysis and Microbiology, IRCCS Cà Granda Maggiore Hospital Foundation, Milan, Italy; (4) Department of Clinical Sciences and Community Health, Milan, Italy

(1) University of Calgary, Calgary, Alberta, Canada; (2) Watermeadow Medical, Witney, UK

(1) Department of Neurology, Ruprecht-Karls-University Heidelberg, Germany; (2) Departmentof Internal Medicine I, Ruprecht-Karls-University Heidelberg, Germany

(1) Cardiovascular Center, St. Josef – Hospital, Ruhr University Bochum, Bochum, Germany

(1) Center for Molecular and Vascular Biology, University of Leuven, Belgium; (2) Department of Vascular Medicine and Haemostasis, University Hospitals Leuven, Belgium; (3) Clinical Department, ThromboGenics, Belgium; (4) Clinical Development, BioInvent International, Sweden; (5) Department of Clinical Medicine, University of Insubria, Italy; (6) Department of Epidemiology, University of Maastricht, The Netherlands; (7) Department of Vascular Medicine, Academic Medical Center Amsterdam, The Netherlands; (8) Department of VascularSurgery, University Medical Center Utrecht, The Netherlands

(1) Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; (2) Department of Medicine, Academic Medical Center, Amsterdam, The Netherlands

(1) Department of Clinical Medicine, Insubria University, Varese, Italy; (2) Internal Medicine Department, Emergency Department, Santa Croce and Carle General Hospital, Cuneo, Italy; (3) Department of Cardiology, Hospital of Tradate, Italy; (4) Department of Clinical Medicine, University of Insubria, Italy; (5) Department of Medical and Surgical Care, University of Florence, Italy

(1) Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada; (2) Department of Chemistry Biochemistry, University of Windsor, Windsor,Ontario, Canada

(1) Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark; (2) Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark; (3) Department of Clinical Biochemistry, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; (4) Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; (5) Department of Haematology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

(1) Department of Clinical Chemistry Hematology, Atrium Medical Center Parkstad, Heerlen, The Netherlands; (2) Department of Clinical Chemistry Hematology, Zuwe Hofpoort Hospital, Woerden, The Netherlands; (3) Department of Clinical Chemistry Hematology, Groene Hart Hospital, Gouda, The Netherlands; (4) Department of Cardiology, Atrium Medical Center Parkstad, Heerlen, The Netherlands; (5) Department of Internal Medicine, Atrium Medical Center Parkstad, Heerlen, The Netherlands

(1) Service de diabétologie, Hôtel Dieu de Paris, APHP and Université Paris Descartes, Paris France; (2) Services des explorations fonctionnelles, Hôpital Louis Mourier, APHP andUniversité Paris Denis Diderot, Paris, France

(1) Regional Reference Center for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico IIUniversity Hospital, Naples, Italy; (2) Department of Transfusion Medicine and Hematology, Carlo Poma Hospital,Mantova, Italy

(1) University of Sydney, ANZAC Research Institute and Department of Cardiology, Concord Hospital, Sydney, New South Wales, Australia; (2) The George Institute for Global Health, Sydney, New South Wales, Australia

(1) Heilongjiang Key Laboratory of Blood and Hematopoietic System Diseases, Heilongjiang Institute of Hematology and Oncology, Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China; (2) Department of Medicine, VA Boston Healthcare System, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA; (3) Heilongjiang Institute of Hematology and Oncology, Department of Hematology, Harbin, China

(1) Heilongjiang Institute of Hematology and Oncology, Department of Hematology, Harbin, China; (2) Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin, China; (3) Department of Medicine, VA Boston Healthcare System, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA

(1) INSERM U872, Centre de Recherche des Cordeliers, Paris-Descartes Université, Pierre et Marie Curie Université, Paris, France

(1) Radiologia – DISSAL, Università di Genova, Italy; (2) Direzione Scientifica – Unità di Farmacologia Clinica eSperimentazioni Cliniche, IRCCS Istituto „G. Gaslini“, Genova, Italy; (3) Dipartimento di Medicina Clinica e Sperimentale. Università di Napoli, Italy; (4) Dipartimento di Medicina – Scienze dell’Invecchiamento. Università di Chieti-Pescara, Italy; (5) Unità di Trombosi ed Emostasi – IRCCS Istituto „G. Gaslini“, Genova, Italy; (6) Dipartimento di Ortopedia, PoliclinicoUniversitario di Milano, Italy; (7) Centro di Emofila e Trombosi „AB Bonomi“, Policlinico Universitario di Milano, Italy; (8) Dipartimento di Medicina Interna – AOU Parma, Italy; (9) Istituto di Anatomia Umana – DIMES, Università di Genova, Italy; (10) Centro Emofilia – AOU “Careggi“ Firenze, Italy

(1) Centre for Cardiovascular Sciences, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

(1) Lund University, Department of Laboratory Medicine, Skåne University Hospital, Malmö, Sweden

(1) Department of Surgery, Section of Vascular Surgery, Conrad Jobst Vascular Research Laboratories, University of Michigan, Ann Arbor, Michigan, USA; (2) Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, Michigan, USA

(1) Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; (2) Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; (3) Department of Pharmacology, Temple University School of Medicine,Philadelphia, Pennsylvania, USA

(1) High Technology Research Center, Showa Pharmaceutical University, Higashi Tamagawa Gakuen, Machida, Tokyo Japan; (2) Department of Molecular and Cellular Pathophysiology, Showa Pharmaceutical University, Higashi Tamagawa Gakuen, Machida, Tokyo Japan; (3) Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmaceutical and Life Science, Horinouchi, Hachioji, Tokyo, Japan

(1) Centro de Investigación Cardiovascular, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau and IIB-Santpau, Barcelona, Spain; (2) CIBEROBN Instituto de Salud Carlos III, Barcelona, Spain; (3) Cátedra de Investigación Cardiovascular, (UAB-HSCSP-Fundación Jesús Serra), Barcelona, Spain

(1) Department of Clinical and Experimental Medicine, Federico II University, Naples; (2) Istituto Nazionale di Statistica, Palermo; (3) Medical School, University of Ferrara, Ferrara, Italy

(1) Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, USA; (2) Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA; (3) Department of Medicine, University of Chicago, Chicago, Illinois, USA; (4) Pharmaceutical Sciences Section, College of Pharmacy, Qatar University, Doha, Qatar; (5) Univeristy of North Carolina Institute for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina, USA

(1) Thrombosis Research Institute, London, UK; (2) University College London, London, UK

(1) The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; (2) Neuroprotection Research Laboratory, Departments of Neurology and Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Charlestown, Massachussetts, USA; (3) Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, USA

(1) Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; (2) Northwestern University, Feinberg School of Medicine, Philadelphia, Pennsylvania, USA; (3) Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; (4) Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Philadelphia, Pennsylvania, USA; (5) Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

(1) Department of Pharmacy and Pharmacology, University of Bath, Bath, UK; (2) Department of Veterinary Basic Sciences, Royal Veterinary College, University of London, London, UK; (3) Consortium for Mitochondrial Research (CfMR), University College London, London, UK; (4) Department of Biology and Biotechnology, University of Pavia, Pavia, Italy; (5) Institute of Human Development, The University of Manchester, Manchester, UK; (6) Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, Manchester, UK; (7) Department of Drug Discovery, Nevada Cancer Institute, Las Vegas, Nevada, USA; (8) Department of Neurology, Columbia University Medical Center, New York, New York, USA

(1) Department of Cardiovascular Sciences, University of Leicester, Leicester, UK

(1) Department of Laboratory Medicine,University of Groningen, University Medical Centre Groningen, the Netherlands; (2) Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, the Netherlands

(1) Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada; (2) Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; (3) Department of Medicine, McMaster University, Hamilton, Ontario, Canada

(1) Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, UK

(1) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan; (2) Department of Biochemistry and Biophysics, University of Rochester School, Rochester, New York, USA

(1) Molecular Pathology Laboratory, Pathology Department, University of Otago, Christchurch, New Zealand; (2) Department of Paediatric Hematology, Children’s Hospital of Michigan, Detroit, Michigan, USA

(1) Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

(1) Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece; (2) Department of Cellular Physiology, “George Papanicolaou” Research Center of Oncology, “Saint Savvas” Anticancer Hospital, Athens, Greece

(1) University of Padua Medical School, Department of Cardiologic, Thoracic and Vascular Sciences, Second Chair of Internal Medicine, Padua, Italy; (2) Department of Laboratory Diagnostics and Cellular Therapy, IRCCS, C.R.O., Aviano, Pordenone, Italy; (3) Pharmaceutical Chemistry and Pharmacology Department, University of Padua, Italy

(1) Karolinska Institute, Department of Medicine-Solna, Clinical Pharmacology Unit, Karolinska University Hospital-Solna, Stockholm, Sweden

(1) Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium

(1) Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan

(1) Department for Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, the Netherlands; (2) Division of Clinical Chemistry, Department of Molecular Medicine and Surgery and Center of Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden